Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases

BACKGROUND: Tumor mutational burden (TMB) and density of tumor-infiltrating lymphocytes (TIL) have been postulated as predictive biomarkers for immunotherapy. Therefore, we investigated the concordance of TMB and TIL of primary/extracranial renal cell carcinoma (RCC) specimens and matched brain meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Steindl, A., Alpar, D., Heller, G., Mair, M.J., Gatterbauer, B., Dieckmann, K., Widhalm, G., Hainfellner, J.A., Schmidinger, M., Bock, C., Müllauer, L., Preusser, M., Berghoff, A.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890370/
https://www.ncbi.nlm.nih.gov/pubmed/33588158
http://dx.doi.org/10.1016/j.esmoop.2021.100057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890370/
https://www.ncbi.nlm.nih.gov/pubmed/33588158
http://dx.doi.org/10.1016/j.esmoop.2021.100057

Ejemplares similares